Aker Biomarine AS (AKBM) — Financial Flexibility Index
Aker Biomarine AS (AKBM) has a Financial Flexibility Index of -0.01x as of June 2025. Free cash flow of Nkr-2.30 Million (operating CF Nkr-6.90 Million minus capex Nkr4.60 Million) represents 0% of total liabilities (Nkr237.50 Million). Check AKBM capex plus investments ratio to assess the company's total reinvestment commitment from operating cash flow.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Aker Biomarine AS Financial Flexibility Index (2016–2024)
Historical Financial Flexibility Index trend for Aker Biomarine AS across 9 annual periods. For the full cash flow conversion analysis, see cash flow conversion of Aker Biomarine AS.
Annual Financial Flexibility Index for Aker Biomarine AS (2016–2024)
Year-by-year free cash flow to debt coverage for Aker Biomarine AS. Explore debt repayment capacity of Aker Biomarine AS to assess how comfortably operating cash covers total debt obligations.
| Year | Flexibility Index | Free Cash Flow (NOK) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2024 | 0.17x | Nkr35.30 Million | Nkr12.20 Million | Nkr213.50 Million | ▼ -21.2% |
| 2023 | 0.21x | Nkr96.70 Million | Nkr47.40 Million | Nkr460.60 Million | ▲ +52.9% |
| 2022 | 0.14x | Nkr61.20 Million | Nkr15.10 Million | Nkr445.80 Million | ▼ -35.1% |
| 2021 | 0.21x | Nkr81.84 Million | Nkr729.00K | Nkr387.12 Million | ▲ +353.1% |
| 2020 | -0.08x | Nkr-27.33 Million | Nkr-51.04 Million | Nkr327.26 Million | ▼ -132.3% |
| 2019 | 0.26x | Nkr139.22 Million | Nkr12.31 Million | Nkr537.68 Million | ▼ -10.1% |
| 2018 | 0.29x | Nkr72.41 Million | Nkr7.89 Million | Nkr251.43 Million | ▼ -23.9% |
| 2017 | 0.38x | Nkr120.37 Million | Nkr9.17 Million | Nkr318.12 Million | ▲ +144.5% |
| 2016 | 0.15x | Nkr31.78 Million | Nkr20.88 Million | Nkr205.32 Million | — |